MX2019011220A - Compuesto de pirrolopiridina novedoso, metodo de preparacion del mismo y uso del mismo. - Google Patents
Compuesto de pirrolopiridina novedoso, metodo de preparacion del mismo y uso del mismo.Info
- Publication number
- MX2019011220A MX2019011220A MX2019011220A MX2019011220A MX2019011220A MX 2019011220 A MX2019011220 A MX 2019011220A MX 2019011220 A MX2019011220 A MX 2019011220A MX 2019011220 A MX2019011220 A MX 2019011220A MX 2019011220 A MX2019011220 A MX 2019011220A
- Authority
- MX
- Mexico
- Prior art keywords
- producing same
- pyrrolopyridine derivative
- novel pyrrolopyridine
- chemical formula
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se refiere a un nuevo compuesto de pirrolopiridina representado por la Fórmula química I, un racemato o un estereoisómero del mismo, o una sal farmacéuticamente aceptable del mismo; y un método para preparar el mismo. Un compuesto representado por la Fórmula química I presenta una alta selectividad y actividad antiviral contra el virus de inmunodeficiencia humana (VIH), con baja toxicidad, por lo que es útil como agente terapéutico para la infección viral, en particular la infección por VIH.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2017/003194 WO2018174320A1 (ko) | 2017-03-24 | 2017-03-24 | 신규한 피롤로피리딘 유도체, 이의 제조방법 및 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019011220A true MX2019011220A (es) | 2019-11-01 |
Family
ID=63584472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019011220A MX2019011220A (es) | 2017-03-24 | 2017-03-24 | Compuesto de pirrolopiridina novedoso, metodo de preparacion del mismo y uso del mismo. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11214570B2 (es) |
| EP (1) | EP3604303B1 (es) |
| JP (1) | JP6781848B2 (es) |
| KR (1) | KR102148294B1 (es) |
| CN (1) | CN110461837B (es) |
| AU (1) | AU2017405244C9 (es) |
| BR (1) | BR112019019982A2 (es) |
| CA (1) | CA3057586C (es) |
| DK (1) | DK3604303T3 (es) |
| ES (1) | ES2938335T3 (es) |
| HU (1) | HUE061404T2 (es) |
| MX (1) | MX2019011220A (es) |
| PL (1) | PL3604303T3 (es) |
| PT (1) | PT3604303T (es) |
| RU (1) | RU2733723C1 (es) |
| WO (1) | WO2018174320A1 (es) |
| ZA (1) | ZA201906848B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519409A1 (en) | 2016-09-28 | 2019-08-07 | Gilead Sciences, Inc. | Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection |
| KR20220023187A (ko) * | 2020-08-20 | 2022-03-02 | 에스티팜 주식회사 | 피롤로피리딘 유도체 및 이들의 용도 |
| CN117015542A (zh) * | 2021-01-11 | 2023-11-07 | St制药株式会社 | 吡咯并吡啶衍生物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007534739A (ja) * | 2004-04-26 | 2007-11-29 | ファイザー・インク | ピロロピリジン誘導体及びｈｉｖインテグラーゼ酵素阻害剤としてのその使用 |
| EA019259B1 (ru) * | 2007-11-16 | 2014-02-28 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
| AR076601A1 (es) | 2009-05-21 | 2011-06-22 | Chlorion Pharma Inc | Pirimidinas como agentes terapeuticos |
| US8609653B2 (en) * | 2011-07-15 | 2013-12-17 | Glaxosmithkline Llc | Azaindole compounds and methods for treating HIV |
| WO2013073875A1 (ko) | 2011-11-15 | 2013-05-23 | 한국화학연구원 | 신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법 |
| CA2876370A1 (en) * | 2012-07-12 | 2014-01-16 | Viiv Healthcare Uk Limited | Compounds and methods for treating hiv |
| CN104704127A (zh) | 2012-07-13 | 2015-06-10 | 莱雅公司 | 体外诊断受试者的薄皮状态的方法及相关应用 |
| KR101592370B1 (ko) * | 2014-06-09 | 2016-02-11 | 한국화학연구원 | 신규한 피롤로피리딘 유도체 및 이의 hiv 저해제로서의 용도 |
-
2017
- 2017-03-24 DK DK17901680.3T patent/DK3604303T3/da active
- 2017-03-24 ES ES17901680T patent/ES2938335T3/es active Active
- 2017-03-24 PT PT179016803T patent/PT3604303T/pt unknown
- 2017-03-24 BR BR112019019982A patent/BR112019019982A2/pt active IP Right Grant
- 2017-03-24 MX MX2019011220A patent/MX2019011220A/es unknown
- 2017-03-24 PL PL17901680.3T patent/PL3604303T3/pl unknown
- 2017-03-24 JP JP2019551450A patent/JP6781848B2/ja active Active
- 2017-03-24 RU RU2019133665A patent/RU2733723C1/ru active
- 2017-03-24 WO PCT/KR2017/003194 patent/WO2018174320A1/ko unknown
- 2017-03-24 AU AU2017405244A patent/AU2017405244C9/en active Active
- 2017-03-24 US US16/497,255 patent/US11214570B2/en active Active
- 2017-03-24 EP EP17901680.3A patent/EP3604303B1/en active Active
- 2017-03-24 CN CN201780088818.5A patent/CN110461837B/zh active Active
- 2017-03-24 HU HUE17901680A patent/HUE061404T2/hu unknown
- 2017-03-24 CA CA3057586A patent/CA3057586C/en active Active
- 2017-03-24 KR KR1020197031007A patent/KR102148294B1/ko active IP Right Grant
-
2019
- 2019-10-17 ZA ZA2019/06848A patent/ZA201906848B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018174320A1 (ko) | 2018-09-27 |
| CA3057586A1 (en) | 2018-09-27 |
| BR112019019982A2 (pt) | 2020-04-28 |
| KR20190141152A (ko) | 2019-12-23 |
| PL3604303T3 (pl) | 2023-04-11 |
| CA3057586C (en) | 2022-05-03 |
| ZA201906848B (en) | 2021-06-30 |
| PT3604303T (pt) | 2023-02-14 |
| CN110461837A (zh) | 2019-11-15 |
| EP3604303A4 (en) | 2020-10-07 |
| DK3604303T3 (da) | 2023-02-06 |
| ES2938335T3 (es) | 2023-04-10 |
| AU2017405244C1 (en) | 2021-02-11 |
| HUE061404T2 (hu) | 2023-06-28 |
| US20200377498A1 (en) | 2020-12-03 |
| RU2733723C1 (ru) | 2020-10-06 |
| AU2017405244C9 (en) | 2021-03-04 |
| JP6781848B2 (ja) | 2020-11-04 |
| US11214570B2 (en) | 2022-01-04 |
| AU2017405244B9 (en) | 2020-10-22 |
| CN110461837B (zh) | 2022-06-17 |
| AU2017405244B2 (en) | 2020-10-01 |
| EP3604303B1 (en) | 2023-01-18 |
| AU2017405244A1 (en) | 2019-11-07 |
| KR102148294B1 (ko) | 2020-08-26 |
| EP3604303A1 (en) | 2020-02-05 |
| JP2020511482A (ja) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501881A1 (en) | Amide compounds for the treatment of hiv | |
| PH12019500335A1 (en) | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection | |
| NZ729150A (en) | Antiretroviral agents | |
| CL2019002204A1 (es) | Compuestos inhibidores del vih. | |
| NZ631762A (en) | 5-membered heteroaryls and their use as antiviral agents | |
| PH12017501258A1 (en) | Pyrazine compounds for the treatment of infectious diseases | |
| CL2020000886A1 (es) | Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih. | |
| NZ631726A (en) | Therapeutic compounds for the treatment of viral infections | |
| PH12017500281B1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| NZ631738A (en) | (hetero) arylacetamide derivatives as antiretroviral agents | |
| MX2017007814A (es) | Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| MX2017012393A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| AU2018253590A1 (en) | Imidazopyridazine compounds | |
| MX2021015056A (es) | Compuesto de pirrolopirimidina y uso del mismo. | |
| MX2020010949A (es) | Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones viricas. | |
| CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
| MX2019011220A (es) | Compuesto de pirrolopiridina novedoso, metodo de preparacion del mismo y uso del mismo. | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| WO2015187850A3 (en) | Compounds and methods for treatment of ocular disorders | |
| CO2020001375A2 (es) | Derivado de adamantilmetilamina y uso del mismo como producto farmacéutico | |
| MX2018015990A (es) | Compuestos terapeuticos. | |
| PH12019501027A1 (en) | Therapeutic drug or prophylactic drug for diabetic nephropathy | |
| MX2022002720A (es) | Inhibidor de magl, procedimiento de preparacion y uso del mismo. | |
| PH12019500082A1 (en) | Therapeutic agent for glaucoma | |
| MX2019011173A (es) | Compuesto que contiene silicio para la resistencia a la infeccion por el virus de la hepatitis c. |